HIV / AIDS in the News

Breakthrough antibody therapies offer hope for HIV treatment - Tech Explorist

 

Gilead posts Phase 1 data for annual HIV PrEP drug (GILD) - Seeking Alpha

 

Immune response may be harnessed to control HIV, primary trial results suggest - Medical Xpress

 

Addressing Long COVID Challenges in People Living With HIV - AJMC.com Managed Markets Network

 

Almost a Quarter of Trans Individuals Worldwide Have HIV/AIDS, Study Shows - Managed Healthcare Executive

 

A once-yearly PrEP? Gilead's lenacapavir shows promise as company plots phase 3 - FiercePharma

 

First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet - BioSpace

 

Gilead presents data for once-yearly lenacapavir for HIV prevention - TipRanks

 

Gilead reports progress in HIV prevention with lenacapavir - Investing.com

 

Kenya’s HIV patients, including children, on edge as US stops aid - VOA Africa

 

Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study - The Lancet

 

First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet - Business Wire

 

Gilead plans to skip from Phase 1 to Phase 3 with once-yearly HIV prevention drug - Endpoints News

 

‘Miracle’ Aids drug ‘may give protection for a year’ - The Telegraph

 

HIV prevention medication ‘could one day be a yearly jab’ – study suggests - The Independent

 

Altered KEGG pathways are associated with different immunologic responses to antiretroviral therapy in HIV-infected men who have sex with men - BMC Infectious Diseases

 

Couples-based HIV counseling improves testing, viral suppression - Healio

 

Positive Outlook on Immunocore Holdings’ Innovative HIV Program Justifies Buy Rating - TipRanks

 

Impact of US funding freeze on HIV programmes in Tanzania - UNAIDS

 

Potential HIV, hepatitis exposure at Toronto gynecology clinic has patients worried - Global News Kingston

 

Hundreds of Scientists, Doctors, Activists Rally for HIV Research Funding - Medpage Today

 

Two More People May Be Cured of HIV After Stem Cell Transplants - POZ

 

3-12-25 dhs launches program to offer free, at-home hiv/sti testing kits - Radio Plus

 

Will infants finally have access to a highly effective HIV drug? - Devex

 

HIV Increases Risk for Developing Thyroid Disorders - Physician's Weekly

 

Fear grows in Kenya for HIV patients as US aid cut halts drugs - Yahoo

 

Broadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ART - Medpage Today

 

At CROI, HIV cure trials raise hopes for broader applicability - BioWorld Online

 

Loss of US assistance hampering Tajikistan’s efforts to contain HIV – UN agency - bne IntelliNews

 

Self-Testing in HIV Shows Promise in Early Studies - AJMC.com Managed Markets Network